The University of Hamburg is a university in Hamburg, Germany. It was founded on 28 March 1919 by combining the previous General Lecture System, the Hamburg Colonial Institute, and the Academic College.

During the past decade, University of Hamburg conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Hamburg" #1 sponsor was "Catabasis Pharmaceuticals" with 2 trials, followed by "University of Luebeck" with 2 trials sponsored, "CRISPR Therapeutics AG" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Dr. med. Mahir Karakas" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Hamburg" #1 collaborator was "Children's Hospital of Philadelphia" with 1 trials as a collaborator, "Martin-Luther-Universität Halle-Wittenberg" with 1 trials as a collaborator, "Nationwide Children's Hospital" with 1 trials as a collaborator, "Targeted Genetics Corporation" with 1 trials as a collaborator and "University of Hamburg-Eppendorf" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "University of Hamburg" are "Adult B Cell ALL" (1 trials), "Aesthetics" (1 trials), "Anaplastic Astrocytoma" (1 trials), "Atopic Dermatitis" (1 trials) and "B-cell Lymphoma" (1 trials). Many other conditions were trialed in "University of Hamburg" in a lesser frequency.

Most popular intervention types in "University of Hamburg" are "Drug" (9 trials), "Biological" (4 trials), "Other" (4 trials), "Behavioral" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Edasalonexent" (2 trials), "Azacitidine" (1 trials), "Biotin" (1 trials) and "Botulinum toxin type A" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Hamburg" are 12 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Hamburg". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in University of Hamburg, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Hamburg, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".

University of Hamburg has several departments that took part in Clinical trials: "University of Hamburg, Faculty of Clinical Psychology and Psychotherapy" - 2 trials, "Psychotherapeutische Hoschschulambulanz Universität Hamburg" - 2 trials